1311315-85-1,MFCD18785597
Catalog No.:AA009YI1

1311315-85-1 | benzyl 3-(chlorosulfonyl)azetidine-1-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$111.00   $78.00
- +
250mg
95%
in stock  
$189.00   $133.00
- +
500mg
95%
in stock  
$315.00   $221.00
- +
1g
95%
in stock  
$474.00   $332.00
- +
5g
95%
in stock  
$1,413.00   $989.00
- +
10g
95%
in stock  
$2,092.00   $1,465.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA009YI1
Chemical Name:
benzyl 3-(chlorosulfonyl)azetidine-1-carboxylate
CAS Number:
1311315-85-1
Molecular Formula:
C11H12ClNO4S
Molecular Weight:
289.7353
MDL Number:
MFCD18785597
SMILES:
O=C(N1CC(C1)S(=O)(=O)Cl)OCc1ccccc1
Properties
Computed Properties
 
Complexity:
394  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.6  

Downstream Synthesis Route

[1]Zhersh,Sergey;Buryanov,VolodymyrV.;Karpenko,OleksandrV.;Grygorenko,OleksandrO.;Tolmachev,AndreyA.[Synthesis,2011,#22,p.3669-3674]

[2]CurrentPatentAssignee:SCHROEDINGERLLC;NIMBUSTHERAPEUTICSINC-WO2017/40757,2017,A1

[3]CurrentPatentAssignee:EPIZYME,INC.-WO2018/102419,2018,A1

[1]Zhersh,Sergey;Buryanov,VolodymyrV.;Karpenko,OleksandrV.;Grygorenko,OleksandrO.;Tolmachev,AndreyA.[Synthesis,2011,#22,p.3669-3674]

[2]CurrentPatentAssignee:Galderma(in:EQTPartners);EqtPartnersAB-WO2022/54005,2022,A1

[1]Synthesis,2011,p.3669-3674

[2]Patent:WO2017/40757,2017,A1

[3]Patent:WO2018/102419,2018,A1

[4]Patent:US2018/271837,2018,A1

[1]CurrentPatentAssignee:EPIZYME,INC.-WO2018/102419,2018,A1Locationinpatent:Paragraph0329;0337;0338;0339

[2]CurrentPatentAssignee:Galderma(in:EQTPartners);EqtPartnersAB-WO2022/54005,2022,A1Locationinpatent:Paragraph0106;0126-0127

[3]CurrentPatentAssignee:Galderma(in:EQTPartners);EqtPartnersAB-WO2022/54005,2022,A1Locationinpatent:Paragraph0106;0126-0127

[4]Locationinpatent:experimentalpartZhersh,Sergey;Buryanov,VolodymyrV.;Karpenko,OleksandrV.;Grygorenko,OleksandrO.;Tolmachev,AndreyA.[Synthesis,2011,#22,p.3669-3674]

[5]CurrentPatentAssignee:SCHROEDINGERLLC;NIMBUSTHERAPEUTICSINC-WO2017/40757,2017,A1Locationinpatent:Paragraph00485

[6]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-US2018/271837,2018,A1Locationinpatent:Paragraph0167-0168

[7]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2020/58913,2020,A1Locationinpatent:Page/Pagecolumn42

[1]Grygorenko,OleksandrO.;Zhersh,Sergey;Oliinyk,BohdanV.;Shishkin,OlegV.;Tolmachev,AndreyA.[TetrahedronAsymmetry,2014,vol.25,#3,p.229-237]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1311315-85-1 Molecular Formula|1311315-85-1 MDL|1311315-85-1 SMILES|1311315-85-1 benzyl 3-(chlorosulfonyl)azetidine-1-carboxylate
Catalog No.: AA009YI1
1311315-85-1,MFCD18785597
1311315-85-1 | benzyl 3-(chlorosulfonyl)azetidine-1-carboxylate
Pack Size: 100mg
Purity: 95%
in stock
$111.00 $78.00
Pack Size: 250mg
Purity: 95%
in stock
$189.00 $133.00
Pack Size: 500mg
Purity: 95%
in stock
$315.00 $221.00
Pack Size: 1g
Purity: 95%
in stock
$474.00 $332.00
Pack Size: 5g
Purity: 95%
in stock
$1,413.00 $989.00
Pack Size: 10g
Purity: 95%
in stock
$2,092.00 $1,465.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA009YI1
Chemical Name: benzyl 3-(chlorosulfonyl)azetidine-1-carboxylate
CAS Number: 1311315-85-1
Molecular Formula: C11H12ClNO4S
Molecular Weight: 289.7353
MDL Number: MFCD18785597
SMILES: O=C(N1CC(C1)S(=O)(=O)Cl)OCc1ccccc1
Properties
Complexity: 394  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 4  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.6  
Downstream Synthesis Route
1315368-95-6    1311315-85-1 

[1]Zhersh,Sergey;Buryanov,VolodymyrV.;Karpenko,OleksandrV.;Grygorenko,OleksandrO.;Tolmachev,AndreyA.[Synthesis,2011,#22,p.3669-3674]

[2]CurrentPatentAssignee:SCHROEDINGERLLC;NIMBUSTHERAPEUTICSINC-WO2017/40757,2017,A1

[3]CurrentPatentAssignee:EPIZYME,INC.-WO2018/102419,2018,A1

501-53-1    1311315-85-1 

[1]Zhersh,Sergey;Buryanov,VolodymyrV.;Karpenko,OleksandrV.;Grygorenko,OleksandrO.;Tolmachev,AndreyA.[Synthesis,2011,#22,p.3669-3674]

[2]CurrentPatentAssignee:Galderma(in:EQTPartners);EqtPartnersAB-WO2022/54005,2022,A1

128117-22-6    1311315-85-1 

[1]Synthesis,2011,p.3669-3674

[2]Patent:WO2017/40757,2017,A1

[3]Patent:WO2018/102419,2018,A1

[4]Patent:US2018/271837,2018,A1

128117-23-7    1311315-85-1 

[1]CurrentPatentAssignee:EPIZYME,INC.-WO2018/102419,2018,A1Locationinpatent:Paragraph0329;0337;0338;0339

[2]CurrentPatentAssignee:Galderma(in:EQTPartners);EqtPartnersAB-WO2022/54005,2022,A1Locationinpatent:Paragraph0106;0126-0127

[3]CurrentPatentAssignee:Galderma(in:EQTPartners);EqtPartnersAB-WO2022/54005,2022,A1Locationinpatent:Paragraph0106;0126-0127

[4]Locationinpatent:experimentalpartZhersh,Sergey;Buryanov,VolodymyrV.;Karpenko,OleksandrV.;Grygorenko,OleksandrO.;Tolmachev,AndreyA.[Synthesis,2011,#22,p.3669-3674]

[5]CurrentPatentAssignee:SCHROEDINGERLLC;NIMBUSTHERAPEUTICSINC-WO2017/40757,2017,A1Locationinpatent:Paragraph00485

[6]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-US2018/271837,2018,A1Locationinpatent:Paragraph0167-0168

[7]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2020/58913,2020,A1Locationinpatent:Page/Pagecolumn42

1311315-85-1    278185-22-1    1552285-41-2 

[1]Grygorenko,OleksandrO.;Zhersh,Sergey;Oliinyk,BohdanV.;Shishkin,OlegV.;Tolmachev,AndreyA.[TetrahedronAsymmetry,2014,vol.25,#3,p.229-237]

Building Blocks More >
124309-70-2
124309-70-2
N-benzyl-2-chloro-8-methoxyquinazolin-4-amine
AA009YX6 | MFCD30721684
1270372-26-3
1270372-26-3
2-Amino-2-cyclobutylethan-1-ol
AA009ZF3 | MFCD18660155
1374652-48-8
1374652-48-8
5-Bromo-2-hydrazino-3-(trifluoromethyl)pyridine
AA009ZZ3 | MFCD22375529
1427460-92-1
1427460-92-1
Ethyl 3-bromo-6-fluoroimidazo[1,2-a]pyridine-2-carboxylate
AA00A0FL | MFCD23159158
1250680-31-9
1250680-31-9
5-cyclopropyl-1-ethyl-1H-pyrazole-4-carboxylic acid
AA00A0X7 | MFCD14619945
1227946-51-1
1227946-51-1
HIF Phd Inhibitor 4
AA00A1D1 | MFCD22683865
1220017-06-0
1220017-06-0
4-(2-Aminoacetyl)piperazin-2-one hydrochloride
AA00A2ES | MFCD13561982
1225713-29-0
1225713-29-0
5-Bromo-2-(methylsulfonamido)benzoic acid
AA00A5IG | MFCD00452520
134812-28-5
134812-28-5
3-(Thiazol-4-yl)aniline
AA00A8EM | MFCD09864282
1303974-96-0
1303974-96-0
1-tert-Butyl 3-methyl 5-oxopiperidine-1,3-dicarboxylate
AA00AADS | MFCD18909956
Submit
© 2017 AA BLOCKS, INC. All rights reserved.